Cargando…

Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine

Detalles Bibliográficos
Autores principales: De Groot, AS, Moise, L, Koita, O, Sangare, K, Levitz, L, Rozenhal, J, Koty, Z, Tounkara, K, Ardito, M, Boyle, CM, Rochas, M, Martin, W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441331/
http://dx.doi.org/10.1186/1742-4690-9-S2-P295
_version_ 1782243264037912576
author De Groot, AS
Moise, L
Koita, O
Sangare, K
Levitz, L
Rozenhal, J
Koty, Z
Tounkara, K
Ardito, M
Boyle, CM
Rochas, M
Martin, W
author_facet De Groot, AS
Moise, L
Koita, O
Sangare, K
Levitz, L
Rozenhal, J
Koty, Z
Tounkara, K
Ardito, M
Boyle, CM
Rochas, M
Martin, W
author_sort De Groot, AS
collection PubMed
description
format Online
Article
Text
id pubmed-3441331
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34413312012-09-18 Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine De Groot, AS Moise, L Koita, O Sangare, K Levitz, L Rozenhal, J Koty, Z Tounkara, K Ardito, M Boyle, CM Rochas, M Martin, W Retrovirology Poster Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441331/ http://dx.doi.org/10.1186/1742-4690-9-S2-P295 Text en Copyright ©2012 De Groot et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
De Groot, AS
Moise, L
Koita, O
Sangare, K
Levitz, L
Rozenhal, J
Koty, Z
Tounkara, K
Ardito, M
Boyle, CM
Rochas, M
Martin, W
Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine
title Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine
title_full Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine
title_fullStr Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine
title_full_unstemmed Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine
title_short Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine
title_sort further confirmation of broadly conserved, highly immunogenic cross-clade hiv ctl epitopes for inclusion in the gaia hiv vaccine
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441331/
http://dx.doi.org/10.1186/1742-4690-9-S2-P295
work_keys_str_mv AT degrootas furtherconfirmationofbroadlyconservedhighlyimmunogeniccrosscladehivctlepitopesforinclusioninthegaiahivvaccine
AT moisel furtherconfirmationofbroadlyconservedhighlyimmunogeniccrosscladehivctlepitopesforinclusioninthegaiahivvaccine
AT koitao furtherconfirmationofbroadlyconservedhighlyimmunogeniccrosscladehivctlepitopesforinclusioninthegaiahivvaccine
AT sangarek furtherconfirmationofbroadlyconservedhighlyimmunogeniccrosscladehivctlepitopesforinclusioninthegaiahivvaccine
AT levitzl furtherconfirmationofbroadlyconservedhighlyimmunogeniccrosscladehivctlepitopesforinclusioninthegaiahivvaccine
AT rozenhalj furtherconfirmationofbroadlyconservedhighlyimmunogeniccrosscladehivctlepitopesforinclusioninthegaiahivvaccine
AT kotyz furtherconfirmationofbroadlyconservedhighlyimmunogeniccrosscladehivctlepitopesforinclusioninthegaiahivvaccine
AT tounkarak furtherconfirmationofbroadlyconservedhighlyimmunogeniccrosscladehivctlepitopesforinclusioninthegaiahivvaccine
AT arditom furtherconfirmationofbroadlyconservedhighlyimmunogeniccrosscladehivctlepitopesforinclusioninthegaiahivvaccine
AT boylecm furtherconfirmationofbroadlyconservedhighlyimmunogeniccrosscladehivctlepitopesforinclusioninthegaiahivvaccine
AT rochasm furtherconfirmationofbroadlyconservedhighlyimmunogeniccrosscladehivctlepitopesforinclusioninthegaiahivvaccine
AT martinw furtherconfirmationofbroadlyconservedhighlyimmunogeniccrosscladehivctlepitopesforinclusioninthegaiahivvaccine